MoneyWorks4Me

A minor change in the total revenue was seen in the September 2022 quarter. The total revenue for the quarter stood at Rs. 544.91 millions against Rs. 529.37 millions during year ago period.The Company to register a -35.99%  fall in the net profit for the quarter ended September 2022.Operating Profit reported a sharp decline to 71.62 millions from 83.94 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 544.91 529.37 2.94 1058.91 1042.06 1.62 2196.63 2448.05 -10.27
Other Income 28.72 27.25 5.39 58.52 40.56 44.28 119.93 71.41 67.95
PBIDT 71.62 83.94 -14.68 136.28 167.23 -18.51 314.56 449.80 -30.07
Interest 6.18 1.20 415.00 11.22 3.09 263.11 13.55 2.71 400.00
PBDT 65.44 82.74 -20.91 125.06 164.49 -23.97 301.25 447.39 -32.67
Depreciation 11.75 9.74 20.64 21.70 19.45 11.57 39.48 40.35 -2.16
PBT 53.69 73.00 -26.45 103.36 145.04 -28.74 261.77 407.04 -35.69
TAX 17.71 16.79 5.48 28.71 34.86 -17.64 63.86 115.32 -44.62
Deferred Tax 3.51 0.12 2825.00 4.21 0.06 6916.67 1.40 2.31 -39.39
PAT 35.98 56.21 -35.99 74.65 110.18 -32.25 197.91 291.72 -32.16
Equity 940.00 829.95 13.26 940.00 829.95 13.26 862.45 789.95 9.18
PBIDTM(%) 13.14 15.86 -17.11 12.87 16.05 -19.80 14.32 18.37 -22.06
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..